S
Shanghai Changjin Biotechnology
At a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 9.1/100
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jun 2023 | $14M | $173M | Grand Flight Investment · Jinqiu Fund · Grand Mount Capital · Shengshan Asset Management | ↗ |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Shanghai Changjin Biotechnology in its local ecosystem
The Shanghai Changjin Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Grand Flight Investment
Jinqiu Fund
Grand Mount Capital
Shengshan Asset Management- DDDa Rui Xia Ding
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Shanghai Changjin Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Shanghai Changjin Biotechnology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.